Integra LifeSciences Holdings Corporation Company Profile (NASDAQ:IART)

About Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Integra LifeSciences Holdings Corporation logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:IART
  • CUSIP: 45798520
  • Web: www.integralife.com
Capitalization:
  • Market Cap: $3.83911 billion
  • Outstanding Shares: 78,078,000
Average Prices:
  • 50 Day Moving Avg: $50.61
  • 200 Day Moving Avg: $49.50
  • 52 Week Range: $37.71 - $56.42
P/E:
  • Trailing P/E Ratio: 59.94
  • Foreward P/E Ratio: 21.84
  • P/E Growth: 2.32
Sales & Book Value:
  • Annual Revenue: $1.05 billion
  • Price / Sales: 3.65
  • Book Value: $11.55 per share
  • Price / Book: 4.26
Profitability:
  • EBITDA: $240.98 million
  • Net Margins: 6.27%
  • Return on Equity: 16.79%
  • Return on Assets: 7.35%
Debt:
  • Debt-to-Equity Ratio: 0.97%
  • Current Ratio: 3.46%
  • Quick Ratio: 2.14%
Misc:
  • Average Volume: 566,150 shs.
  • Beta: 0.72
  • Short Ratio: 6.29
 

Frequently Asked Questions for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

What is Integra LifeSciences Holdings Corporation's stock symbol?

Integra LifeSciences Holdings Corporation trades on the NASDAQ under the ticker symbol "IART."

When did Integra LifeSciences Holdings Corporation's stock split? How did Integra LifeSciences Holdings Corporation's stock split work?

Shares of Integra LifeSciences Holdings Corporation split before market open on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly created shares were distributed to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences Holdings Corporation stock prior to the split would have 200 shares after the split.

How were Integra LifeSciences Holdings Corporation's earnings last quarter?

Integra LifeSciences Holdings Corporation (NASDAQ:IART) posted its quarterly earnings results on Wednesday, July, 26th. The company reported $0.45 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.45. The firm had revenue of $282.16 million for the quarter, compared to the consensus estimate of $283.58 million. Integra LifeSciences Holdings Corporation had a return on equity of 16.79% and a net margin of 6.27%. Integra LifeSciences Holdings Corporation's revenue for the quarter was up 13.2% compared to the same quarter last year. During the same period last year, the company earned $0.40 earnings per share. View Integra LifeSciences Holdings Corporation's Earnings History.

When will Integra LifeSciences Holdings Corporation make its next earnings announcement?

Integra LifeSciences Holdings Corporation is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Integra LifeSciences Holdings Corporation.

What guidance has Integra LifeSciences Holdings Corporation issued on next quarter's earnings?

Integra LifeSciences Holdings Corporation updated its FY17 earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $1.88-1.94 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.92. The company issued revenue guidance of $1.125-1.14 billion, compared to the consensus revenue estimate of $1.13 billion.

Where is Integra LifeSciences Holdings Corporation's stock going? Where will Integra LifeSciences Holdings Corporation's stock price be in 2017?

9 brokerages have issued twelve-month price targets for Integra LifeSciences Holdings Corporation's stock. Their forecasts range from $46.00 to $65.00. On average, they expect Integra LifeSciences Holdings Corporation's stock price to reach $53.56 in the next twelve months. View Analyst Ratings for Integra LifeSciences Holdings Corporation.

Who are some of Integra LifeSciences Holdings Corporation's key competitors?

Who are Integra LifeSciences Holdings Corporation's key executives?

Integra LifeSciences Holdings Corporation's management team includes the folowing people:

  • Stuart M. Essig Ph.D., Independent Chairman of the Board
  • Peter J. Arduini, President, Chief Executive Officer, Director
  • Glenn G. Coleman, Chief Financial Officer, Principal Accounting Officer, Corporate Vice President
  • Lisa Evoli, Corporate Vice President, Chief Human Resources Officer
  • Kenneth Burhop Ph.D., Chief Scientific Officer, Corporate Vice President
  • John Mooradian, Corporate Vice President - Global Operations and Supply Chain
  • Richard D. Gorelick, Corporate Vice President, General Counsel, Administration, Secretary
  • Robert T. Davis Jr., Corporate Vice President, President — Specialty Surgical Solutions
  • Judith E. O'Grady R.N., Corporate Vice President - Global Regulatory Affairs
  • Daniel L. Reuvers, Corporate Vice President, President - Specialty Surgical Solutions

How do I buy Integra LifeSciences Holdings Corporation stock?

Shares of Integra LifeSciences Holdings Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Integra LifeSciences Holdings Corporation's stock price today?

One share of Integra LifeSciences Holdings Corporation stock can currently be purchased for approximately $49.15.


MarketBeat Community Rating for Integra LifeSciences Holdings Corporation (NASDAQ IART)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  256 (Vote Underperform)
Total Votes:  512
MarketBeat's community ratings are surveys of what our community members think about Integra LifeSciences Holdings Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Integra LifeSciences Holdings Corporation (NASDAQ:IART) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $53.56 (8.96% upside)
Consensus Price Target History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Price Target History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Analysts' Ratings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/12/2017Jefferies Group LLCReiterated RatingBuy$58.00N/AView Rating Details
9/18/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$60.00LowView Rating Details
9/12/2017Barclays PLCReiterated RatingEqual Weight$47.00 -> $53.00HighView Rating Details
7/27/2017Raymond James Financial, Inc.Boost Price TargetOutperform$51.00 -> $55.00LowView Rating Details
7/26/2017Cantor FitzgeraldSet Price TargetBuy$65.00LowView Rating Details
5/2/2017Royal Bank Of CanadaReiterated RatingSector Perform -> Sector Perform$46.00 -> $48.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00LowView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00N/AView Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00N/AView Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50N/AView Rating Details
7/13/2016J P Morgan Chase & CoInitiated CoverageOverweightN/AView Rating Details
11/12/2015Citigroup Inc.Initiated CoverageBuy$37.50N/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Earnings by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Earnings History by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$0.47N/AView Earnings Details
7/26/2017Q2 2017$0.45$0.45$283.58 million$282.16 millionViewN/AView Earnings Details
4/26/2017Q1 17$0.40$0.39$254.19 million$258.60 millionViewN/AView Earnings Details
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.73$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.63$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
2017 EPS Consensus Estimate: $1.91
2018 EPS Consensus Estimate: $2.27
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.38$0.48$0.42
Q2 20174$0.43$0.47$0.45
Q3 20174$0.42$0.50$0.46
Q4 20174$0.55$0.65$0.59
Q1 20183$0.45$0.51$0.47
Q2 20183$0.54$0.58$0.56
Q3 20183$0.53$0.58$0.56
Q4 20183$0.61$0.74$0.68
Q1 20191$0.54$0.54$0.54
Q2 20191$0.62$0.62$0.62
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Insider Ownership Percentage: 21.50%
Institutional Ownership Percentage: 84.90%
Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/4/2017Donald E Morel JrDirectorBuy10,000$49.25$492,500.00View SEC Filing  
8/3/2017Donald E Morel JrDirectorBuy2,500$49.29$123,225.00View SEC Filing  
8/1/2017Barbara B HillDirectorBuy5,050$49.33$249,116.50View SEC Filing  
5/25/2017Stuart EssigDirectorSell135,000$49.90$6,736,500.00View SEC Filing  
5/23/2017Stuart EssigDirectorSell140,000$48.01$6,721,400.00View SEC Filing  
5/4/2017Glenn ColemanVPSell13,865$45.91$636,542.15View SEC Filing  
5/4/2017James M SullivanDirectorSell15,658$45.89$718,545.62View SEC Filing  
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Latest Headlines for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Source:
DateHeadline
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation to Post Q3 2017 Earnings of $0.45 Per Share, Northcoast Research Forecasts (IART)
www.americanbankingnews.com - October 16 at 2:14 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation's (IART) "Buy" Rating Reaffirmed at Jefferies Group LLC
www.americanbankingnews.com - October 15 at 5:50 PM
nasdaq.com logoIntegra LifeSciences to Host Third Quarter 2017 Earnings Results Conference ...
www.nasdaq.com - October 12 at 6:11 AM
finance.yahoo.com logoIntegra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017
finance.yahoo.com - October 12 at 6:11 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - October 10 at 4:34 PM
finance.yahoo.com logoIntegra's (IART) Revize/Revize-X Boosts Tissue Technology Arm
finance.yahoo.com - October 10 at 12:46 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - October 9 at 1:22 PM
finance.yahoo.com logoIntegra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive Surgery
finance.yahoo.com - October 6 at 8:09 PM
finance.yahoo.com logoIntegra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line
finance.yahoo.com - October 5 at 11:10 AM
americanbankingnews.com logo Analysts Expect Integra LifeSciences Holdings Corporation (IART) Will Post Quarterly Sales of $286.77 Million
www.americanbankingnews.com - October 5 at 10:36 AM
finance.yahoo.com logoIntegra LifeSciences launches SurgiMend® PRS Meshed Collagen Matrix for Plastic and Reconstructive Surgery
finance.yahoo.com - October 4 at 4:01 PM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : October 4, 2017
finance.yahoo.com - October 4 at 4:01 PM
finance.yahoo.com logoIntegra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line
finance.yahoo.com - October 4 at 4:01 PM
finance.yahoo.com logoIntegra LifeSciences Launches Integra® SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
finance.yahoo.com - October 3 at 9:52 AM
finance.yahoo.com logoIntegra LifeSciences Launches Integra® SurgiMend(TM) PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
finance.yahoo.com - October 3 at 9:52 AM
finance.yahoo.com logoIntegra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
finance.yahoo.com - October 2 at 6:33 PM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 30 at 3:08 PM
reuters.com logoFTC allows Integra to buy J&J’s Codman neuro business, with conditions
www.reuters.com - September 28 at 3:44 PM
reuters.com logoBRIEF-Integra lifesciences reports preliminary assessment of damage to Puerto Rico facility
www.reuters.com - September 26 at 10:45 AM
streetinsider.com logoForm 8-K INTEGRA LIFESCIENCES For: Sep 26
www.streetinsider.com - September 26 at 10:45 AM
finance.yahoo.com logoIntegra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study
finance.yahoo.com - September 22 at 2:13 PM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : September 21, 2017
finance.yahoo.com - September 22 at 2:13 PM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : September 20, 2017
finance.yahoo.com - September 20 at 4:03 PM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Stock Rating Reaffirmed by Oppenheimer Holdings, Inc.
www.americanbankingnews.com - September 18 at 8:58 PM
americanbankingnews.com logo$286.37 Million in Sales Expected for Integra LifeSciences Holdings Corporation (IART) This Quarter
www.americanbankingnews.com - September 16 at 7:44 AM
americanbankingnews.com logoFinancial Comparison: Integra LifeSciences Holdings Corporation (IART) versus Sientra (SIEN)
www.americanbankingnews.com - September 16 at 12:10 AM
seekingalpha.com logoIntegra LifeSciences Holdings' (IART) CEO Peter Arduini Presents at Morgan Stanley Healthcare Conference (Transcript)
seekingalpha.com - September 13 at 1:02 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation's (IART) "Equal Weight" Rating Reiterated at Barclays PLC
www.americanbankingnews.com - September 12 at 4:30 PM
rttnews.com logoIntegra LifeSciences To Sell Certain Neurosurgery Assets To Natus Medical
www.rttnews.com - September 11 at 8:12 PM
finance.yahoo.com logoNatus to Acquire Neurosurgery Assets from Integra LifeSciences, Enters Neurosurgery Market
finance.yahoo.com - September 11 at 8:11 PM
finance.yahoo.com logoIntegra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated
finance.yahoo.com - September 11 at 8:11 PM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Earns Buy Rating from Jefferies Group LLC
www.americanbankingnews.com - September 10 at 6:24 AM
americanbankingnews.com logo$286.10 Million in Sales Expected for Integra LifeSciences Holdings Corporation (IART) This Quarter
www.americanbankingnews.com - August 29 at 11:42 AM
finance.yahoo.com logoETFs with exposure to Integra LifeSciences Holdings Corp. : August 24, 2017
finance.yahoo.com - August 25 at 6:54 AM
americanbankingnews.com logoReviewing Integra LifeSciences Holdings Corporation (IART) and ICU Medical (ICUI)
www.americanbankingnews.com - August 18 at 10:18 PM
finance.yahoo.com logoIntegra LifeSciences to Present at Healthcare Conferences in September 2017
finance.yahoo.com - August 18 at 5:01 AM
finance.yahoo.com logoIntegra’s DuraSeal® dural sealant saves healthcare costs according to a study recently published in the Journal of Health Economics and Outcomes Research
finance.yahoo.com - August 11 at 8:11 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.
finance.yahoo.com - August 11 at 8:11 PM
finance.yahoo.com logoETFs with exposure to Integra LifeSciences Holdings Corp. : August 11, 2017
finance.yahoo.com - August 11 at 8:11 PM
americanbankingnews.com logoInsider Buying: Integra LifeSciences Holdings Corporation (IART) Director Acquires 2,500 Shares of Stock
www.americanbankingnews.com - August 4 at 8:40 PM
americanbankingnews.com logoInsider Buying: Integra LifeSciences Holdings Corporation (NASDAQ:IART) Director Buys 10,000 Shares of Stock
www.americanbankingnews.com - August 4 at 8:22 PM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation (IART) Director Purchases $249,116.50 in Stock
www.americanbankingnews.com - August 2 at 8:34 PM
americanbankingnews.com logoEquities Analysts Set Expectations for Integra LifeSciences Holdings Corporation's FY2017 Earnings (IART)
www.americanbankingnews.com - August 2 at 10:38 AM
americanbankingnews.com logoIntegra LifeSciences Holdings Corporation Expected to Earn Q3 2017 Earnings of $0.46 Per Share (IART)
www.americanbankingnews.com - August 2 at 7:02 AM
nasdaq.com logoIntegra LifeSciences Holdings Enters Oversold Territory (IART)
www.nasdaq.com - August 2 at 1:22 AM
americanbankingnews.com logoQ4 2017 EPS Estimates for Integra LifeSciences Holdings Corporation (IART) Lifted by Northcoast Research
www.americanbankingnews.com - August 1 at 11:57 AM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017
finance.yahoo.com - July 28 at 10:44 PM
americanbankingnews.com logoQ3 2017 Earnings Estimate for Integra LifeSciences Holdings Corporation (IART) Issued By Jefferies Group
www.americanbankingnews.com - July 28 at 11:26 AM
americanbankingnews.com logoOppenheimer Holdings Weighs in on Integra LifeSciences Holdings Corporation's Q3 2017 Earnings (NASDAQ:IART)
www.americanbankingnews.com - July 28 at 11:26 AM
seekingalpha.com logoIntegra LifeSciences Holdings (IART) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 1:27 AM

Social

Chart

Integra LifeSciences Holdings Corporation (IART) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.